Latest Oncogene Stories
Researchers at the Hebrew University of Jerusalem have discovered that Vav1 â€“ an oncogene (cancer-causing gene) found in recent years to be one of the factors in tumorous tissue growth -- plays a wider role in several types of cancer than had previously been thought.
The immune system may play a critical role in ensuring the success of certain types of cancer therapies.
New hypothesis in the FASEB Journal suggests balance between NF-kB and p53 signaling is a promising target for new drugs.
Researchers at UCLA's Jonsson Comprehensive Cancer Center have discovered a new cell signaling pathway that controls cell growth and development, a pathway that, when defective, helps promote the formation of several major forms of human cancer, including lymphoma and leukemia.
The first study of Ewing's sarcoma that screened hundreds of genes based on how they affect cell growth has identified two potential anti-cancer drug targets.
Malignant gliomas are the most common subtype of primary brain tumor â€“ and one of the deadliest.
The central dogma of molecular biology, as proposed in 1970 by Francis Crick and James Watson, holds that genetic information is transferred from DNA to functional proteins by way of messenger RNA (mRNA).
The tumor suppressor Retinoblastoma represses DNA replication genes during senescence.
4-protein complex provides new target for thwarting cancer migration, invasion.
Researchers have found that one particularly aggressive type of blood cancer, mixed lineage leukemia (MLL), has an unusual way to keep the molecular motors running.